journal article·2025-02-05Open access

Deuterated Nanopolymers for Renal and Lymphatic Imaging via Quantitative Deuterium MRI

Lisa M. Fries, Elton T. Montrazi, Hyla Allouche-Arnon, Felipe Opazo, Amnon Bar-Shir, Lucio Frydman, Stefan Glöggler

Nano Letters· Volume 25· Issue 5

Abstract

High Resolution Image Download MS PowerPoint Slide Deuterium ( 2 H) MRI is an emerging tool for noninvasive imaging. We explore the integration of 2 H MRI with deuterated multifunctional nanopolymers for deuterated particle imaging (DPI). To this end, amine-terminated G5-polyamidoamine (PAMAM) dendrimers were labeled with deuterated acetyl surface groups, leading to highly 2 H-loaded bioparticles, making them ideal for imaging studies. The accumulation of ∼5 nm PAMAM dendrimers in the kidneys could then be seen by 2 H MRI with high submillimeter resolution. The natural abundance HDO signal provided an internal concentration reference to these measurements, leading to quantitative dynamic maps showing distinct nanopolymer uptakes within the renal compartments. Further, these nanopolymers allowed us to obtain in vivo maps of activity in the lymph nodes in an inflammatory rodent leg model, demonstrating these deuterated nanopolymers’ potential as a novel class of contrast agents for the quantitative mapping of physiological processes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Lanthanide and Transition Metal Complexes · Catalytic Processes in Materials Science

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NMR Signal Enhancement Group

Max Planck Institute for Multidisciplinary Sciences

Center for Biostructural Imaging of Neurodegeneration of the University Medical Center

Department of Chemical and Biological Physics

Weizmann Institute of Science

Department of Molecular Chemistry and Materials Science

Institute for Neuro- and Sensory Physiology

University Medical Center

Funding

Israel Science Foundation · Minerva Foundation · Deutsche Forschungsgemeinschaft · German-Israeli Foundation for Scientific Research and Development · Max-Planck-Gesellschaft · Israel Cancer Research Fund

References (48)

Show source-provided references
1. 10.1126/sciadv.aat731410.1126/sciadv.aat7314 ↗
2. 10.1002/mrm.2890610.1002/mrm.28906 ↗
3. 10.1126/sciadv.adm860010.1126/sciadv.adm8600 ↗
4. 10.3390/polym1522436910.3390/polym15224369 ↗
5. 10.3390/ijms2406543010.3390/ijms24065430 ↗
6. 10.1016/j.jddst.2024.10589610.1016/j.jddst.2024.105896 ↗
7. 10.2147/IJN.S24315510.2147/IJN.S243155 ↗
8. 10.1038/nbt117110.1038/nbt1171 ↗
9. 10.1016/j.colsurfb.2021.11183710.1016/j.colsurfb.2021.111837 ↗
10. 10.1295/polymj.17.11710.1295/polymj.17.117 ↗
11. 10.3390/biom908033010.3390/biom9080330 ↗
12. 10.2174/156720181866621102116044110.2174/1567201818666211021160441 ↗
13. 10.1002/mrm.191031010210.1002/mrm.1910310102 ↗
14. 10.2217/nnm.14.11310.2217/nnm.14.113 ↗
15. 10.2217/17435889.3.5.70310.2217/17435889.3.5.703 ↗
16. 10.1021/acs.biomac.6b0060510.1021/acs.biomac.6b00605 ↗
17. 10.1021/acsami.6b1407510.1021/acsami.6b14075 ↗
18. 10.1021/bc025633c10.1021/bc025633c ↗
19. 10.1042/BST035006110.1042/BST0350061 ↗
20. 10.1002/nbm.101510.1002/nbm.1015 ↗
21. 10.1021/acs.biomac.2c0008810.1021/acs.biomac.2c00088 ↗
22. 10.1002/anie.20050147310.1002/anie.200501473 ↗
23. 10.1021/acs.nanolett.5b0451710.1021/acs.nanolett.5b04517 ↗
24. 10.1038/nnano.2013.6510.1038/nnano.2013.65 ↗
25. 10.1038/nbt112110.1038/nbt1121 ↗
26. 10.1021/acs.nanolett.0c0254910.1021/acs.nanolett.0c02549 ↗
27. 10.1021/acsnano.1c0104010.1021/acsnano.1c01040 ↗
28. 10.1016/j.neuroimage.2021.11863910.1016/j.neuroimage.2021.118639 ↗
29. 10.1016/j.neuroimage.2022.11928410.1016/j.neuroimage.2022.119284 ↗
30. 10.3390/magnetochemistry901000610.3390/magnetochemistry9010006 ↗
31. 10.1016/j.pnmrs.2023.02.00210.1016/j.pnmrs.2023.02.002 ↗
32. 10.1021/bc060388910.1021/bc0603889 ↗
33. 10.1021/nl034349710.1021/nl0343497 ↗
34. 10.1021/ma021540e10.1021/ma021540e ↗
35. 10.1021/mp200463e10.1021/mp200463e ↗
36. 10.1038/s41598-023-47301-710.1038/s41598-023-47301-7 ↗
37. 10.1006/snmr.2002.006310.1006/snmr.2002.0063 ↗
38. 10.1002/VIW.2020012010.1002/VIW.20200120 ↗
39. 10.3390/nano709025110.3390/nano7090251 ↗
40. 10.1039/C5CS00288E10.1039/C5CS00288E ↗
41. 10.1016/j.drudis.2019.03.00110.1016/j.drudis.2019.03.001 ↗
42. 10.1002/jmri.2014710.1002/jmri.20147 ↗
43. 10.1159/00009060810.1159/000090608 ↗
44. 10.2967/jnumed.117.20382810.2967/jnumed.117.203828 ↗
45. 10.2967/jnumed.116.17271810.2967/jnumed.116.172718 ↗
46. 10.3390/pharmaceutics1503088810.3390/pharmaceutics15030888 ↗
47. 10.3389/fnagi.2023.113207710.3389/fnagi.2023.1132077 ↗
48. 10.1038/s41392-023-01481-w10.1038/s41392-023-01481-w ↗